Abcam PLC
LSE:ABC
Abcam PLC
Total Current Liabilities
Abcam PLC
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abcam PLC
LSE:ABC
|
Total Current Liabilities
£203.8m
|
CAGR 3-Years
65%
|
CAGR 5-Years
44%
|
CAGR 10-Years
30%
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Total Current Liabilities
$39.4m
|
CAGR 3-Years
66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Total Current Liabilities
$44.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Total Current Liabilities
$49.5m
|
CAGR 3-Years
34%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Total Current Liabilities
£139m
|
CAGR 3-Years
36%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Total Current Liabilities
£128.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
See Also
What is Abcam PLC's Total Current Liabilities?
Total Current Liabilities
203.8m
GBP
Based on the financial report for Jun 30, 2022, Abcam PLC's Total Current Liabilities amounts to 203.8m GBP.
What is Abcam PLC's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
30%
Over the last year, the Total Current Liabilities growth was 205%. The average annual Total Current Liabilities growth rates for Abcam PLC have been 65% over the past three years , 44% over the past five years , and 30% over the past ten years .